Patents Assigned to Protechtion Unlimited, Inc.
  • Nerve growth factor as a vaccine adjuvant
    Patent number: 6572866
    Abstract: A vaccination method utilizes a pharmaceutical combination for enhancing vaccine effectiveness. The method utilizes an immune response-triggering vaccine capable of stimulating production in an immunodeficient animal antibodies to a disease-causing agent foreign to the animal. As an adjuvant, a vaccine effectiveness-enhancing amount of Nerve Growth Factor (NGF) is administered, which enhances production and affinity of the antibodies in the animal, in response to the vaccine.
    Type: Grant
    Filed: June 1, 1999
    Date of Patent: June 3, 2003
    Assignee: Protechtion Unlimited, Inc.
    Inventor: Maria Torcia